Article: Angiosonics Inc. Says it Will Begin Overseas Sales of Device That Uses Ultrasound to Dissolve Blood Clots

ANAHEIM, Calif., March 17 /PRNewswire/ -- Angiosonics Inc., a Research Triangle Park, N.C.-based medical device company specializing in therapeutic ultrasound technologies to dissolve blood clots, said today it will begin international sales of its ACOLYSIS(TM) System and Probe this summer. The catheter-based device uses high-frequency sound waves to turn blood clots back to blood, and restore circulation in blocked blood vessels. Such blockages in blood vessels can lead to heart attack, stroke, and limb loss. Initial international sales for the device will focus on patients with blood clots in coronary (heart) vessels.

Angiosonics is currently applying to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!